Sort
40,608 grants matching “prostate cancer”
Prostate Section
$2,070,275Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical Research
$2,070,000Lingjun Li · University Of Wisconsin-Madison · S10 · FY2011 · RR
Translational Multimodality " Antibody" Therapy
$2,069,586University Of California Davis · P01 · FY2004 · CA
A CANCER TAXONOMY BASED ON GENE EXPRESSION PATTERNS
$2,067,424Stanford University · U01 · FY2003 · CA
Protein-mediated membrane remodeling
$2,066,193Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Center for Cell-based Therapy - Cures
$2,065,053Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK
$2,065,030Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
Effects of Public Information in Cancer (EPIC Center)
$2,064,973Robert C. Hornik · University Of Pennsylvania · P50 · FY2006 · CA
The Co-Clinical Project: Informing clinical trials using preclinical mouse models
$2,064,367Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · RC2 · FY2009 · CA
Effects of Public Information in Cancer (EPIC Center)
$2,061,995University Of Pennsylvania · P50 · FY2004 · CA
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$2,061,095Sanku Mallik · North Dakota State University · P20 · FY2016 · GM
University of Wisconsin Prostate SPORE
$2,061,062David F Jarrard · University Of Wisconsin-Madison · P50 · FY2023 · CA
Studies of Occupational Cancer (Pesticides)
$2,060,486Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Center for Clinical Cancer Metabolism
$2,060,450Daniel Crooks · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Selective Targeting of Pancreatic Cancer SPORE
$2,057,187Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Novel Targets for Immunotherapy
$2,057,118Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
$2,055,750Michael M. Shen · Columbia University Health Sciences · P01 · FY2023 · CA
Androgen Receptor Action in Castration Resistant Prostate Cancer
$2,055,706Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2015 · CA
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
$2,055,632Haian Fu · Emory University · P01 · FY2024 · CA
PHARMACOLOGIC INHIBITION OF LIPOGENESIS SUPPRESSES AR AND ITS SPLICE VARIANTS TO INHIBIT PROGRESSION OF CASTRATION-RESISTANT PROSTATE CANCER
$2,054,702University Of Washington · · FY2017 · Department of the Army
Computational Pathology Research for Cancer Modeling, Diagnostics and Biomarkers
$2,053,644Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
PLCO Trial Etiologic and Early Marker Study
$2,050,613Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
$2,049,085Sanjiv S Gambhir · Stanford University · U54 · FY2017 · CA
SWOG Biospecimen Bank to Support NCI NCTN
$2,048,483Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA
CENTER FOR PSYCHO-ONCOLOGY RESEARCH
$2,046,384University Of Miami Coral Gables · P50 · FY2000 · CA